1-20 of 26
epigenetics
Close
Sort by
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.
https://doi.org/10.1182/asheducation-2018.1.264
Published: 2018
Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.
https://doi.org/10.1182/asheducation-2018.1.63
Published: 2018
Journal Articles

How and when to decide between epigenetic therapy and chemotherapy in patients with AML

Hervé Dombret, Raphael Itzykson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 45–53.
https://doi.org/10.1182/asheducation-2017.1.45
Published: 2017
Journal Articles

Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies

Shaji Kumar
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 518–524.
https://doi.org/10.1182/asheducation-2017.1.518
Published: 2017
Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.
https://doi.org/10.1182/asheducation-2016.1.284
Published: 2016
Journal Articles

Mutations in AML: prognostic and therapeutic implications

Courtney D. DiNardo, Jorge E. Cortes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 348–355.
https://doi.org/10.1182/asheducation-2016.1.348
Published: 2016
Journal Articles

Molecularly targeted therapies for acute myeloid leukemia

Eytan M. Stein
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 579–583.
https://doi.org/10.1182/asheducation-2015.1.579
Published: 2015
Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.
https://doi.org/10.1182/asheducation-2015.1.317
Published: 2015
Journal Articles

Epigenetic targeting and personalized approaches for AML

Gail J. Roboz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 44–51.
https://doi.org/10.1182/asheducation-2014.1.44
Published: 2014
Journal Articles

The evolving genomic landscape of myeloproliferative neoplasms

Jyoti Nangalia, Tony R. Green
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 287–296.
https://doi.org/10.1182/asheducation-2014.1.287
Published: 2014
Journal Articles

Dissecting follicular lymphoma: high versus low risk

Sonali M. Smith
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 561–567.
https://doi.org/10.1182/asheducation-2013.1.561
Published: 2013
Journal Articles

Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP

Leandro Cerchietti, John P. Leonard
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 591–595.
https://doi.org/10.1182/asheducation-2013.1.591
Published: 2013
Journal Articles

Focus on the epigenome in the myeloproliferative neoplasms

Eunhee Kim, Omar Abdel-Wahab
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 538–544.
https://doi.org/10.1182/asheducation-2013.1.538
Published: 2013
Journal Articles

The molecular genetic makeup of acute lymphoblastic leukemia

Charles G. Mullighan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 389–396.
https://doi.org/10.1182/asheducation.V2012.1.389.3798360
Published: 2012
Journal Articles

New insights in the biology of Hodgkin lymphoma

Ralf Küppers
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 328–334.
https://doi.org/10.1182/asheducation.V2012.1.328.3798326
Published: 2012
Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.
https://doi.org/10.1182/asheducation.V2012.1.553.3800163
Published: 2012
Journal Articles

Interpreting new molecular genetics in myelodysplastic syndromes

Omar Abdel-Wahab, Maria E. Figueroa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 56–64.
https://doi.org/10.1182/asheducation.V2012.1.56.3798194
Published: 2012
Journal Articles

Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms

Nicholas C. P. Cross
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 208–214.
https://doi.org/10.1182/asheducation-2011.1.208
Published: 2011
Journal Articles

Targeting Epigenetic Programs in MLL -Rearranged Leukemias

Kathrin M. Bernt, Scott A. Armstrong
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 354–360.
https://doi.org/10.1182/asheducation-2011.1.354
Published: 2011